世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本の感染症診断市場規模、現状、見通し2021-2027年


Global and Japan Infectious Diseases Diagnostic Market Size, Status and Forecast 2021-2027

感染症診断薬は、感染する可能性のある病気を、迅速かつ正確な検査結果として確認するために使用されます。 市場分析と洞察。世界の感染症診断市場 感染症診断の世界市場規模は、2020年のXX百万米ドルから202... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年10月22日 US$3,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

感染症診断薬は、感染する可能性のある病気を、迅速かつ正確な検査結果として確認するために使用されます。

市場分析と洞察。世界の感染症診断市場
感染症診断の世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の感染症診断市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界の感染症診断市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の感染症診断市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の感染症診断市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の感染症診断の範囲と市場規模
感染症診断市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のInfectious Diseases Diagnostic市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
尿
血液(Blood
その他

用途別セグメント
病院・外傷センター
診断検査室
リハビリテーションセンター

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ベクトン・ディッキンソン社
Cepheid, Inc.
アボット・ラボラトリーズ
BioMerieux SA
ホログラム・インク(Hologic, Inc.
ダナハー・コーポレーション
テルモフィッシャーサイエンティフィック社
ロシュ・ダイアグノスティックス
アレラ社
DiaSorin S.p.A.
Quidel Corporation
バイオ・ラッド・ラボラトリーズ・インク


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urine
1.2.3 Blood
1.2.4 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Trauma Centers
1.3.3 Diagnostic Laboratories
1.3.4 Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Diseases Diagnostic Market Perspective (2016-2027)
2.2 Infectious Diseases Diagnostic Growth Trends by Regions
2.2.1 Infectious Diseases Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Diseases Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Diseases Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Diseases Diagnostic Industry Dynamic
2.3.1 Infectious Diseases Diagnostic Market Trends
2.3.2 Infectious Diseases Diagnostic Market Drivers
2.3.3 Infectious Diseases Diagnostic Market Challenges
2.3.4 Infectious Diseases Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases Diagnostic Players by Revenue
3.1.1 Global Top Infectious Diseases Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Infectious Diseases Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
3.4 Global Infectious Diseases Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Diseases Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Diagnostic Revenue in 2020
3.5 Infectious Diseases Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Diseases Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Diseases Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases Diagnostic Breakdown Data by Type
4.1 Global Infectious Diseases Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Type (2022-2027)

5 Infectious Diseases Diagnostic Breakdown Data by Application
5.1 Global Infectious Diseases Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Diseases Diagnostic Market Size (2016-2027)
6.2 North America Infectious Diseases Diagnostic Market Size by Type
6.2.1 North America Infectious Diseases Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Infectious Diseases Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Infectious Diseases Diagnostic Market Size by Type (2016-2027)
6.3 North America Infectious Diseases Diagnostic Market Size by Application
6.3.1 North America Infectious Diseases Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Infectious Diseases Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Infectious Diseases Diagnostic Market Size by Application (2016-2027)
6.4 North America Infectious Diseases Diagnostic Market Size by Country
6.4.1 North America Infectious Diseases Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Infectious Diseases Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Infectious Diseases Diagnostic Market Size (2016-2027)
7.2 Europe Infectious Diseases Diagnostic Market Size by Type
7.2.1 Europe Infectious Diseases Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Infectious Diseases Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Infectious Diseases Diagnostic Market Size by Type (2016-2027)
7.3 Europe Infectious Diseases Diagnostic Market Size by Application
7.3.1 Europe Infectious Diseases Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Infectious Diseases Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Infectious Diseases Diagnostic Market Size by Application (2016-2027)
7.4 Europe Infectious Diseases Diagnostic Market Size by Country
7.4.1 Europe Infectious Diseases Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Infectious Diseases Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type
8.2.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application
8.3.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region
8.4.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Diseases Diagnostic Market Size (2016-2027)
9.2 Latin America Infectious Diseases Diagnostic Market Size by Type
9.2.1 Latin America Infectious Diseases Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Diseases Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Diseases Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Infectious Diseases Diagnostic Market Size by Application
9.3.1 Latin America Infectious Diseases Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Diseases Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Diseases Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Infectious Diseases Diagnostic Market Size by Country
9.4.1 Latin America Infectious Diseases Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Diseases Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type
10.2.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application
10.3.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country
10.4.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Details
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Introduction
11.1.4 Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Cepheid, Inc.
11.2.1 Cepheid, Inc. Company Details
11.2.2 Cepheid, Inc. Business Overview
11.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Introduction
11.2.4 Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.2.5 Cepheid, Inc. Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Diseases Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 bioMerieux SA
11.4.1 bioMerieux SA Company Details
11.4.2 bioMerieux SA Business Overview
11.4.3 bioMerieux SA Infectious Diseases Diagnostic Introduction
11.4.4 bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.4.5 bioMerieux SA Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Infectious Diseases Diagnostic Introduction
11.5.4 Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.5.5 Hologic, Inc. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Infectious Diseases Diagnostic Introduction
11.6.4 Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics Infectious Diseases Diagnostic Introduction
11.8.4 Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.8.5 Roche Diagnostics Recent Development
11.9 Alera Inc.
11.9.1 Alera Inc. Company Details
11.9.2 Alera Inc. Business Overview
11.9.3 Alera Inc. Infectious Diseases Diagnostic Introduction
11.9.4 Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.9.5 Alera Inc. Recent Development
11.10 DiaSorin S.p.A.
11.10.1 DiaSorin S.p.A. Company Details
11.10.2 DiaSorin S.p.A. Business Overview
11.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Introduction
11.10.4 DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.10.5 DiaSorin S.p.A. Recent Development
11.11 Quidel Corporation
11.11.1 Quidel Corporation Company Details
11.11.2 Quidel Corporation Business Overview
11.11.3 Quidel Corporation Infectious Diseases Diagnostic Introduction
11.11.4 Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.11.5 Quidel Corporation Recent Development
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Details
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.12.5 Bio-Rad Laboratories, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.

Market Analysis and Insights: Global Infectious Diseases Diagnostic Market
The global Infectious Diseases Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Diseases Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Diseases Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Diseases Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Diseases Diagnostic market.

Global Infectious Diseases Diagnostic Scope and Market Size
Infectious Diseases Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Diseases Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Urine
Blood
Others

Segment by Application
Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratories
bioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Alera Inc.
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urine
1.2.3 Blood
1.2.4 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Trauma Centers
1.3.3 Diagnostic Laboratories
1.3.4 Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Diseases Diagnostic Market Perspective (2016-2027)
2.2 Infectious Diseases Diagnostic Growth Trends by Regions
2.2.1 Infectious Diseases Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Diseases Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Diseases Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Diseases Diagnostic Industry Dynamic
2.3.1 Infectious Diseases Diagnostic Market Trends
2.3.2 Infectious Diseases Diagnostic Market Drivers
2.3.3 Infectious Diseases Diagnostic Market Challenges
2.3.4 Infectious Diseases Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases Diagnostic Players by Revenue
3.1.1 Global Top Infectious Diseases Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Infectious Diseases Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
3.4 Global Infectious Diseases Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Diseases Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Diagnostic Revenue in 2020
3.5 Infectious Diseases Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Diseases Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Diseases Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases Diagnostic Breakdown Data by Type
4.1 Global Infectious Diseases Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Type (2022-2027)

5 Infectious Diseases Diagnostic Breakdown Data by Application
5.1 Global Infectious Diseases Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Diseases Diagnostic Market Size (2016-2027)
6.2 North America Infectious Diseases Diagnostic Market Size by Type
6.2.1 North America Infectious Diseases Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Infectious Diseases Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Infectious Diseases Diagnostic Market Size by Type (2016-2027)
6.3 North America Infectious Diseases Diagnostic Market Size by Application
6.3.1 North America Infectious Diseases Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Infectious Diseases Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Infectious Diseases Diagnostic Market Size by Application (2016-2027)
6.4 North America Infectious Diseases Diagnostic Market Size by Country
6.4.1 North America Infectious Diseases Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Infectious Diseases Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Infectious Diseases Diagnostic Market Size (2016-2027)
7.2 Europe Infectious Diseases Diagnostic Market Size by Type
7.2.1 Europe Infectious Diseases Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Infectious Diseases Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Infectious Diseases Diagnostic Market Size by Type (2016-2027)
7.3 Europe Infectious Diseases Diagnostic Market Size by Application
7.3.1 Europe Infectious Diseases Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Infectious Diseases Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Infectious Diseases Diagnostic Market Size by Application (2016-2027)
7.4 Europe Infectious Diseases Diagnostic Market Size by Country
7.4.1 Europe Infectious Diseases Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Infectious Diseases Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type
8.2.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application
8.3.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region
8.4.1 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Diseases Diagnostic Market Size (2016-2027)
9.2 Latin America Infectious Diseases Diagnostic Market Size by Type
9.2.1 Latin America Infectious Diseases Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Diseases Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Diseases Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Infectious Diseases Diagnostic Market Size by Application
9.3.1 Latin America Infectious Diseases Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Diseases Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Diseases Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Infectious Diseases Diagnostic Market Size by Country
9.4.1 Latin America Infectious Diseases Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Diseases Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type
10.2.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application
10.3.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country
10.4.1 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Details
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Introduction
11.1.4 Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Cepheid, Inc.
11.2.1 Cepheid, Inc. Company Details
11.2.2 Cepheid, Inc. Business Overview
11.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Introduction
11.2.4 Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.2.5 Cepheid, Inc. Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Diseases Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 bioMerieux SA
11.4.1 bioMerieux SA Company Details
11.4.2 bioMerieux SA Business Overview
11.4.3 bioMerieux SA Infectious Diseases Diagnostic Introduction
11.4.4 bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.4.5 bioMerieux SA Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Infectious Diseases Diagnostic Introduction
11.5.4 Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.5.5 Hologic, Inc. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Infectious Diseases Diagnostic Introduction
11.6.4 Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics Infectious Diseases Diagnostic Introduction
11.8.4 Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.8.5 Roche Diagnostics Recent Development
11.9 Alera Inc.
11.9.1 Alera Inc. Company Details
11.9.2 Alera Inc. Business Overview
11.9.3 Alera Inc. Infectious Diseases Diagnostic Introduction
11.9.4 Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.9.5 Alera Inc. Recent Development
11.10 DiaSorin S.p.A.
11.10.1 DiaSorin S.p.A. Company Details
11.10.2 DiaSorin S.p.A. Business Overview
11.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Introduction
11.10.4 DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.10.5 DiaSorin S.p.A. Recent Development
11.11 Quidel Corporation
11.11.1 Quidel Corporation Company Details
11.11.2 Quidel Corporation Business Overview
11.11.3 Quidel Corporation Infectious Diseases Diagnostic Introduction
11.11.4 Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.11.5 Quidel Corporation Recent Development
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Details
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2016-2021)
11.12.5 Bio-Rad Laboratories, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(diagnostic)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19 10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る